Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119309) titled 'AI-powered non-invasive glucose monitoring for glycaemic control in people with Type 2 diabetes mellitus in North India' on Oct. 9.
Study Type: Interventional
Study Design:
Non-randomized, Active Controlled Trial Method of generating randomization sequence:Not Applicable Method of allocation concealment:Case Record Numbers Blinding and masking:Not Applicable
Primary Sponsor: Indian Council of Medical Research
Condition:
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Intervention:
Intervention1: AI-powered non-invasive glucose monitoring package: AI-powered non-invasive gluc...